ALISO VIEJO, Calif. — Digital transformation company UST has announced a strategic partnership with ThinkBio.Ai®, a provider of AI-driven solutions for biopharmaceutical and healthcare organizations. The collaboration aims to accelerate AI adoption across the life sciences industry, combining UST’s digital transformation expertise with ThinkBio.Ai’s cutting-edge AI-powered research and development capabilities.
Together, the companies plan to deliver integrated solutions that enhance innovation and improve outcomes across the biopharma and healthcare ecosystem. The partnership will support clients in pharmaceutical, biotech, and medical device sectors, driving measurable impact across the research and development pipeline.
“This partnership will bring our unique AI and knowledge-based transformation products and solutions for Research and Discovery (R&D) to UST’s focus on digital transformation capabilities and building Gen AI solutions for different industries, including the life science sector,” said Pradeep Palazhi, Founder and CEO of ThinkBio.Ai. “Together, we will build custom ecosystems to help clients and partners stay ahead in a well-regulated, dynamic, and competitive landscape.”
ThinkBio.Ai has developed a suite of AI-enabled platforms designed to address challenges across the preclinical and clinical R&D process. These include biomarker-driven patient stratification, digital twin-enabled trial matching, and drug repurposing strategies to salvage failed compounds or enhance treatment efficacy through combination therapies.
A key innovation from ThinkBio.Ai is R-COP™ (Research Co-pilot)—an AI-enhanced system that integrates with existing Laboratory Information Management Systems (LIMS) to transform traditional research workflows into dynamic, data-driven operations. The company also leverages its proprietary BioThinkHub™ platform, which aggregates curated biological and clinical insights from both public and private data sources.
“We will integrate ThinkBio.Ai’s AI-powered R&D transformation solutions with UST’s strengths in digital transformation and Gen AI across life sciences,” said Anu Koshy, Life Science Cluster Leader at UST. “This strategic collaboration will drive innovation, accelerate time-to-value, and deliver measurable impact across the research and development value chain for our customers.”
The partnership underscores the growing role of AI and machine learning in transforming biomedical research, clinical trials, and healthcare delivery—especially in highly regulated and competitive global markets.
